missing translation for 'onlineSavingsMsg'
Learn More
Learn More
p57Kip2Ab-6 Mouse Monoclonal Antibody, Epredia™
Deliver accurate, reproducible results with the Epredia™ p57Kip2 Ab-6, Mouse Monoclonal Antibody.
Marca: Epredia MS-1062-RQ
Questo articolo non è restituibile.
Consulta la politica di reso
Descrizione
p57Kip2 (or CDKN1C) is a potent tight-binding inhibitor of several G1 cyclin complexes, and is a negative regulator of cell proliferation. The gene encoding human p57Kip2 is located on chromosome 11p15.5, a region implicated in both sporadic cancers, Wilm's tumor, and Beckwith-Wiedemann syndrome (BWS), a cancer syndrome, making it a tumor suppressor candidate. BWS is characterized by numerous growth abnormalities and an increased risk of childhood tumors. Several types of childhood tumors including Wilms' tumor, adrenocortical carcinoma and rhabdomyosarcoma display a specific loss of maternal 11p15 alleles, suggesting that genomic imprinting plays an important part. This region also contains two other imprinted genes, insulin-like growth factor II (IGF-II) and H19, both of which seem to be implicated in adrenal neoplasms.Host Species: Mouse
Clone: 57P06; same as KP10
Isotype: IgG2b/κ
Species Reactivity: Human and Mouse. Others not known.
Epitope: Not determined
Immunogen: Recombinant human p57Kip2 protein
Molecular Weight: 57kDa
Positive Control: LS174T cells, Colon CA or placenta
Cellular Localization: Nuclear
Recommended for:
- Immunohistochemistry (Formalin/paraffin)
- Western Blotting (Not suitable)
- Immunoprecipitation (Native verified)
Specifica
p57superscriptKip2superscript Ab-6 | |
Monoclonal | |
Unconjugated | |
Recombinant human p57superscriptKip2superscript protein | |
IVD | |
Primary |
Immunohistochemistry (Paraffin), Immunoprecipitation | |
57P06; same as KP10 | |
Mouse | |
12 mL | |
Cell Cycle | |
Ready-to-Use |
Correzione del contenuto del prodotto
Fornite il vostro feedback sul contenuto del prodotto compilando il modulo sottostante.
Titolo del prodotto
Individuate un'opportunità di miglioramento?Condividi una correzione di contenuto